| UTUC | Noncancerous upper tract | UBC | Noncancerous bladder | p-value |
---|---|---|---|---|---|
MAPK/ERK pathway | |||||
 EGFR | 5.28 ± 2.69 | 1.05 ± 0.9 | 2.85 ± 0.9 | 1.05 ± 0.14 | < 0.001a, b, c |
 ELK-1 | 5.00 ± 0.97 | 0.97 ± 0.08 | 3.15 ± 0.72 | 1.07 ± 0.18 | < 0.001a, b, c |
 c-fos | 5.11 ± 1.85 | 1 ± 0.07 | 3.12 ± 0.77 | 1.06 ± 0.16 | < 0.001a, b, c |
Cell cycle regulators | |||||
 Survivin | 12.75 ± 6.28 | 0.98 ± 0.1 | 5.73 ± 1.32 | 1.02 ± 0.15 | < 0.001a, b, c |
 TP53 | 5.75 ± 1.21 | 0.96 ± 0.07 | 3.21 ± 0.8 | 1.03 ± 0.97 | < 0.001a, b, c |
 RB1 | 0.37 ± 0.37 | 1.03 ± 0.08 | 0.50 ± 0.25 | 1.01 ± 0.09 | < 0.001a, b 0.133c |
Oncogenic genes | |||||
 FGFR3 | 5.12 ± 2.82 | 1 ± 0.07 | 2.88 ± 0.60 | 1.06 ± 0.16 | < 0.001a, b, c |
 hTERT | 3.56 ± 1.3 | 1.02 ± 0.09 | 3.28 ± 0.97 | 1.02 ± 0.1 | < 0.001a, b 0.395c |